Sign in Register

Synagis (palivizumab)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: Palivizumab is used in certain infants and young children to prevent serious lung infections (such as pneumonia) that are caused by a certain virus (respiratory syncytial virus-RSV). Palivizumab works by preventing the growth of the virus. This medication is not used to treat RSV infection, but should be continued even if your child gets the RSV infection to prevent a more serious infection.

Generic name: palivizumab
Pronunciation: (PAL-i-VIZ-ue-mab)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Synagis

Intelligence content is not available yet.

Indications

The following indications are listed for Synagis:

  • Respiratory Syncytial Virus Pneumonia Prevention

Also known as: Respiratory Syncytial Virus Pneumonia Prophylaxis, Rsv Pneumonia Prophylaxis.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data